Experts publish recommendations on managing low-level but detectable HIV
An international panel of experts has published new clinical guidelines in The Lancet HIV for managing patients with low-level, detectable HIV viral loads. The framework provides a roadmap for clinicians to distinguish between causes and determine appropriate follow-up actions.
Why it matters
Standardized management of low-level viraemia is crucial for preventing treatment failure and improving long-term patient outcomes.
An international panel of scientists reviewed the evidence to construct a framework of recommendations on the management of low-level but detectable HIV. The guidance, published in The Lancet HIV by Dr Tommaso Clemente and colleagues, brings together evidence from a scoping review and expert judgement in order to create a shared point of reference for clinicians.
While some other guidelines map out some of the scenarios and how to act on them, a thorough approach to low-level but detectable viral load has not been available so far. Clinicians have therefore lacked a clear roadmap for distinguishing between its different possible causes and for managing the more challenging cases. This persistent low but detectable viral load is often called low-level viraemia.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in